2Suppliers
0Customers
1Debt Items
0Related Chains
Grace Therapeutics, Inc. Suppliers
| Ticker | Name | Confidence | Evidence |
| CMOS |
CMOS |
90%
|
We utilize CMOs for the development and production of clinical materials |
| CROS |
CROS |
90%
|
We utilize CROs to perform services related to our clinical trials |
Grace Therapeutics, Inc. Customers
No clients on recordNo downstream customers found in our database for Grace Therapeutics, Inc..
Grace Therapeutics, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
| GRCE-DEBT-9872 |
Warrants outstanding: 0.45 |
90%
|
xbrl warrant detail from xbrl 2025-03-31. |
Grace Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Grace Therapeutics, Inc..
Grace Therapeutics, Inc. Ownership
| Holder | Name | Confidence | Evidence |
| GRCE-OWNER-CERITY-PARTNERS-LLC |
Cerity Partners LLC |
90%
|
13F overlay lists Cerity Partners LLC as top holder; 35 tracked holders. |
Grace Therapeutics, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.